In the Philippines, incentives for drug registration of essential medicines include expedited review processes, reduced registration fees, and potential tax benefits. These measures aim to enhance access to critical medications, ensuring public health needs are met efficiently and affordably, while encouraging pharmaceutical companies to prioritize essential drug availability.